Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Patent
1977-03-28
1982-04-27
Randolph, John D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
424246, 4242485, 42424852, 424270, 424276, 424278, 549 19, 549 21, 549 28, 549 30, 549 38, 549 69, 2603067T, 2603406, 544 98, 548184, A61K 3133, A61K 31385, C07D4072, C07D4092
Patent
active
043271103
ABSTRACT:
Symmetrical N-substituted bis-carbamoyloximino disulfide compounds exhibit outstanding nematocidal, miticidal and insecticidal activity, coupled with substantially reduced mammalian toxicity and phytotoxicity as compared to known pesticidal compounds having a comparable spectrum of activity against insect, arachnid and nematode pests.
REFERENCES:
patent: 3947591 (1976-03-01), Rizzo
patent: 3998963 (1976-12-01), Durden et al.
patent: 4004031 (1977-01-01), Drabek
patent: 4008328 (1977-02-01), Siegle et al.
patent: 4072751 (1978-02-01), D'Silva
Moran W. R.
Randolph John D.
Union Carbide Corporation
Vicari C. J.
LandOfFree
Pesticidal symmetrical N-substituted bis-carbamoyloximino disulf does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pesticidal symmetrical N-substituted bis-carbamoyloximino disulf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pesticidal symmetrical N-substituted bis-carbamoyloximino disulf will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2197638